ClinicalTrials.gg
TerminatedNCT06483113Updated Jul 20, 2025

DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study

An observational study in Myopia, Hyperopia and Presbyopia, sponsored by Alcon Research. Terminated at 12 sites in United States. Open to participants aged 7 Years and older. Per ClinicalTrials.gov, last updated 2025-07-20.

Sponsored by Alcon Research (part of Alcon) · Observational

Why this study was terminated
Management decision
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
192
Ages
7 Years and older
Sex
All
01

Study summary

The purpose of this study is to continuously assess the visual performance and safety of DAILIES TOTAL1 soft contact lenses in a real world setting and broader patient base through routine clinical practices. This activity will be used to continuously support delefilcon A (sphere, toric, and multifocal) soft contact lens regulatory requirements and standards.

Read the detailed description

This study includes a Baseline visit and a Year 1 visit.

The Baseline visit is defined as the first office visit where an eye care professional provided an in-person office biomicroscopy exam to the subject before or during which a DAILIES TOTAL1 sphere, toric, or multifocal soft contact lens prescription was released. The Baseline visit will be retrospective. All assessments at baseline will be obtained from chart reviews.

The Year 1 visit is defined as the visit that occurs 1 year (-2/+4 months) since the Baseline visit during which period the subject is wearing prescribed lenses and a contact lens examination is performed. The Year 1 visit can be either retrospective or prospective in subjects 7 to less than 18 years of age. For subjects 18 years of age and older, the Year 1 visit will be retrospective.

02

Conditions studied

  • Myopia
  • Hyperopia
  • Presbyopia
  • Astigmatism

Keywords

  • Contact lenses
03

In context

Myopia

1,159 studies on the registry are indexed under Myopia; 225 are open to participants now.

This study's enrollment of 192 is above the median of 150 across 204 observational studies indexed under Myopia.

Browse Myopia studies →

Lead sponsor

Alcon Research is the lead sponsor of 624 studies on the registry; 9 are open to participants now.

Of its 112 completed or terminated interventional studies of FDA-regulated products, 102 (91%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects will be recruited from clinical sites located in the United States.

Eligibility criteria

Key Inclusion Criteria:

  • At baseline: 7 years of age or older for sphere and toric wearers, 40 years of age or older for multifocal wearers.
  • Wearers of delefilcon A (sphere, toric, or multifocal) soft contact lenses of the same design in both eyes who have already begun use of the lens type and have purchased at least 3-month supply of lenses at baseline.
  • Best corrected distance visual acuity (BCVA) 20/25 or better in each eye at baseline.
  • Other protocol-defined inclusion criteria may apply.

Key Exclusion Criteria:

  • Any ocular disease or condition that would contraindicate contact lens wear at baseline.
  • Use of systemic or ocular medications that would contraindicate contact lens wear at baseline.
  • Other protocol-defined exclusion criteria may apply.
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
192 participants (actual)
Patient registry
No

Groups and cohorts

  • DAILIES TOTAL1 Sphere

    Delefilcon A spherical soft contact lenses worn in both eyes in a real-world setting

    Device: Delefilcon A spherical soft contact lenses

  • DAILIES TOTAL1 Toric

    Delefilcon A toric soft contact lenses worn in both eyes in a real-world setting

    Device: Delefilcon A toric soft contact lenses

  • DAILIES TOTAL1 Multifocal

    Delefilcon A multifocal soft contact lenses worn in both eyes in a real-world setting

    Device: Delefilcon A multifocal soft contact lenses

Interventions

  • DeviceDelefilcon A spherical soft contact lenses

    Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia)

    Also known as: DAILIES TOTAL1® Spherical Contact Lenses

  • DeviceDelefilcon A toric soft contact lenses

    Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with astigmatism

    Also known as: DAILIES TOTAL1® for Astigmatism Contact Lenses

  • DeviceDelefilcon A multifocal soft contact lenses

    Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with presbyopia

    Also known as: DAILIES TOTAL1® Multifocal Contact Lenses

06

What researchers measure

Primary outcomes

  1. Distance visual acuity (VA) with study lenses at Baseline - Sphere and Toric

    Distance VA will be assessed for each eye individually with study lenses in place and recorded in Snellen. This endpoint is prespecified for DAILIES TOTAL1 spherical contact lenses and DAILIES TOTAL1 for Astigmatism contact lenses.

    Time frame: Baseline

  2. Distance visual acuity with study lenses at Year 1 Follow-up - Sphere and Toric

    Distance VA will be assessed for each eye individually with study lenses in place and recorded in Snellen. This endpoint is prespecified for DAILIES TOTAL1 spherical contact lenses and DAILIES TOTAL1 for Astigmatism contact lenses.

    Time frame: Year 1 Follow-Up

  3. Distance visual acuity with study lenses at Baseline - Multifocal

    Distance visual acuity will be assessed for both eyes together with study lenses in place and recorded in Snellen. This endpoint is prespecified for DAILIES TOTAL1 multifocal contact lenses.

    Time frame: Baseline

  4. Distance visual acuity with study lenses at Year 1 Follow-Up - Multifocal

    Distance visual acuity will be assessed for both eyes together with study lenses in place and recorded in Snellen. This endpoint is prespecified for DAILIES TOTAL1 multifocal contact lenses.

    Time frame: Year 1 Follow-Up

  5. Near visual acuity with study lenses at Baseline - Multifocal

    Near visual acuity will be assessed for both eyes together with study lenses in place and recorded in Snellen. This endpoint is prespecified for DAILIES TOTAL1 multifocal contact lenses.

    Time frame: Baseline

  6. Near visual acuity with study lenses at Year 1 Follow-Up - Multifocal

    Near visual acuity will be assessed for both eyes together with study lenses in place and recorded in Snellen. This endpoint is prespecified for DAILIES TOTAL1 multifocal contact lenses.

    Time frame: Year 1 Follow-Up

  7. Incidence of corneal infiltrative events

    A corneal infiltrate is a single or group of inflammatory cells in the normally clear cornea.

    Time frame: Up to Year 1

  8. Incidence of microbial keratitis

    Microbial keratitis is a sight-threatening infection of the cornea.

    Time frame: Up to Year 1

07

Study locations

12 sites
  • Westview Optometry
    San Diego, California 92129, United States
  • Scripps Optometric Group
    San Diego, California 92131, United States
  • Dr. Walker and Associates
    Ponte Vedra Beach, Florida 32082, United States
  • Advanced Eyecare Specialists
    West Palm Beach, Florida 33405, United States
  • The Eye Doctors Inc
    Eden Prairie, Minnesota 55344, United States
  • Cornea and Contact Lens Institute of Minnesota
    Edina, Minnesota 55436, United States
  • Complete Eye Care of Medina
    Medina, Minnesota 55340, United States
  • Koetting Associates
    St Louis, Missouri 63144, United States
  • Center for Ophthalmic and Vision Research
    New York, New York 10022, United States
  • Optometry Group, PLLC
    Memphis, Tennessee 38111, United States
  • Southern Utah Medical Research
    St. George, Utah 84790, United States
  • Spokane Eye Clinic
    Spokane, Washington 99204, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2024 to primary completion in Feb 2025, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 26, 2024
First posted
Jul 3, 2024
StartActual
Nov 26, 2024
Primary completionActual
Feb 27, 2025
CompletionActual
Feb 27, 2025
Last update
Jul 20, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06483113
Lead sponsor
Alcon Research
Responsible party
Sponsor
First posted
Jul 3, 2024
Start date
Nov 26, 2024
Primary completion
Feb 27, 2025
Completion
Feb 27, 2025
Last update
Jul 20, 2025

Study contacts

Clinical Trial Lead, Vision Care
study director · Alcon Research, LLC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion